Brain, Spinal & Leptomeningeal Cancer Emergencies

Identify the Immediate Mechanism

The official neurooncology topics include primary brain tumors, brain and spinal metastases, carcinomatous meningitis, paraneoplastic syndromes, and radiation or chemotherapy complications. A cancer label does not explain the acute event by itself. Determine whether the patient has mass effect, hemorrhage, hydrocephalus, ischemia, seizures, infection, metabolic failure, or treatment toxicity. Each mechanism leads to a different immediate intervention.

A new focal deficit may be an acute stroke, even in a patient with known metastases. Altered consciousness may reflect nonconvulsive seizures or medication accumulation rather than tumor growth. Obtain an examination and relevant imaging, review recent treatment and organ function, and correct glucose and oxygenation while the evaluation proceeds. MRI often characterizes tumor-related disease better than CT, but a rapidly available CT may first identify hemorrhage, major mass effect, or hydrocephalus.

Tumor Edema, Hemorrhage, and CSF Obstruction

Vasogenic edema around a tumor reflects increased vascular permeability and extracellular fluid accumulation. Dexamethasone can reduce symptomatic edema; use a syndrome-appropriate dose and reassess for tapering rather than continuing high doses indefinitely. Monitor hyperglycemia, infection, psychiatric effects, weakness, and gastrointestinal risk. Steroids do not replace surgery for a critically compressive mass or CSF diversion for obstructive hydrocephalus.

If primary CNS lymphoma is suspected and the patient is stable, discuss steroids with the diagnostic team because treatment can reduce biopsy yield. If impending herniation requires emergency therapy, stabilize first and coordinate the diagnostic consequences. A rigid rule to withhold all steroids regardless of clinical danger is inappropriate.

Tumors and metastases can bleed, and cancer-associated thrombosis can coexist with intracranial hemorrhage. Manage the immediate bleeding and mass effect, assess coagulation and drug exposure, and individualize anticoagulation decisions. A seizure caused by an intracranial lesion requires treatment; routine primary seizure prophylaxis in every seizure-free brain-tumor patient is a different question and is not established as universally beneficial.

Spinal Cord and Epidural Disease

Metastatic spinal cord compression can begin with back pain, radicular symptoms, weakness, sensory change, or bladder dysfunction. A patient with cancer and new neurologic findings needs urgent spinal imaging and multidisciplinary assessment. A single symptomatic level does not guarantee that there is only one lesion; imaging coverage is selected for the clinical situation.

Stabilize a potentially unstable spine and discuss corticosteroids, surgery, radiation, or other treatment urgently with the relevant teams. The choice depends on mechanical stability, degree of compression, tumor biology, prior treatment, systemic condition, and patient goals. Do not wait for complete paralysis or established urinary retention to request help. Pain may be absent or unreportable in a sedated patient.

Leptomeningeal and Paraneoplastic Disease

Leptomeningeal metastasis, also called carcinomatous meningitis, can affect multiple cranial nerves, roots, and cerebral regions and can impair CSF circulation. Headache, diplopia, radicular pain, weakness, or hydrocephalus may occur in combination. MRI with appropriate contrast sequences and CSF cytology or other selected studies contribute to diagnosis. An initial negative CSF cytology does not exclude disease; repeat adequate sampling may be needed when safe and clinically useful.

Paraneoplastic neurologic syndromes arise through immune mechanisms rather than direct tumor invasion. Encephalitis, cerebellar dysfunction, neuropathy, or neuromuscular junction disease can precede discovery of the cancer. Interpret antibody findings in the clinical context and search for a relevant malignancy. Tumor treatment and immune treatment are coordinated according to the syndrome; not all intracellular-antigen and cell-surface-antigen disorders respond identically.

Radiation and Drug Complications

Delayed radiation injury can mimic progression, while acute or subacute treatment effects can cause edema, seizures, or cognitive change. MRI perfusion, metabolic imaging, serial studies, and sometimes tissue are selected to distinguish recurrence from treatment effect; no single routine scan feature is perfectly definitive. Radiation can also cause vascular disease and other delayed neurologic complications.

Chemotherapy and targeted or immune therapies can cause encephalopathy, leukoencephalopathy, neuropathy, myopathy, vascular events, or metabolic abnormalities. Consider renal clearance and interactions when symptoms follow a treatment cycle. In an immunosuppressed patient, infection remains a major competing diagnosis. Manage immediately reversible threats while the oncology team evaluates whether the causative therapy must be paused, changed, or treated with a specific rescue strategy.

Sources checked October 17, 2026: EANO–ESMO neurologic complications guideline and brain metastasis guideline.